Protein engineering of antibody molecules for prophylactic and therapeutic applications in man:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Nottingham
Acad. Titles
1993
|
| Schlagworte: | |
| Beschreibung: | XI, 182 S. graph. Darst. |
| ISBN: | 1874695008 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV008551782 | ||
| 003 | DE-604 | ||
| 005 | 19940110 | ||
| 007 | t | ||
| 008 | 931230s1993 d||| |||| 00||| eng d | ||
| 020 | |a 1874695008 |9 1-874695-00-8 | ||
| 035 | |a (OCoLC)29358819 | ||
| 035 | |a (DE-599)BVBBV008551782 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-188 | ||
| 050 | 0 | |a TP248.65.P76 | |
| 082 | 0 | |a 616.0793 |2 20 | |
| 084 | |a XD 3115 |0 (DE-625)152552:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Protein engineering of antibody molecules for prophylactic and therapeutic applications in man |c ed. by Mike Clark |
| 264 | 1 | |a Nottingham |b Acad. Titles |c 1993 | |
| 300 | |a XI, 182 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Antibodies, Monoclonal |x genetics | |
| 650 | 4 | |a Antibodies, Monoclonal |x therapeutic use | |
| 650 | 4 | |a Immunoglobulins |x Biotechnology | |
| 650 | 4 | |a Immunoglobulins |x Therapeutic use | |
| 650 | 4 | |a Protein Engineering | |
| 650 | 4 | |a Protein engineering | |
| 650 | 0 | 7 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Rekombinante DNS |0 (DE-588)4225578-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antikörper |0 (DE-588)4002290-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Antikörper |0 (DE-588)4002290-0 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |D s |
| 689 | 1 | 1 | |a Rekombinante DNS |0 (DE-588)4225578-8 |D s |
| 689 | 1 | |5 DE-188 | |
| 700 | 1 | |a Clark, Mike |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005621045 | ||
Datensatz im Suchindex
| _version_ | 1804122887011958784 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV008551782 |
| callnumber-first | T - Technology |
| callnumber-label | TP248 |
| callnumber-raw | TP248.65.P76 |
| callnumber-search | TP248.65.P76 |
| callnumber-sort | TP 3248.65 P76 |
| callnumber-subject | TP - Chemical Technology |
| classification_rvk | XD 3115 |
| ctrlnum | (OCoLC)29358819 (DE-599)BVBBV008551782 |
| dewey-full | 616.0793 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.0793 |
| dewey-search | 616.0793 |
| dewey-sort | 3616.0793 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01741nam a2200493 c 4500</leader><controlfield tag="001">BV008551782</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19940110 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">931230s1993 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1874695008</subfield><subfield code="9">1-874695-00-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)29358819</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008551782</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TP248.65.P76</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.0793</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3115</subfield><subfield code="0">(DE-625)152552:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protein engineering of antibody molecules for prophylactic and therapeutic applications in man</subfield><subfield code="c">ed. by Mike Clark</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Nottingham</subfield><subfield code="b">Acad. Titles</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 182 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield><subfield code="x">genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins</subfield><subfield code="x">Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein Engineering</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein engineering</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rekombinante DNS</subfield><subfield code="0">(DE-588)4225578-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Rekombinante DNS</subfield><subfield code="0">(DE-588)4225578-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Clark, Mike</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005621045</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV008551782 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:21:00Z |
| institution | BVB |
| isbn | 1874695008 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005621045 |
| oclc_num | 29358819 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-188 |
| owner_facet | DE-355 DE-BY-UBR DE-188 |
| physical | XI, 182 S. graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Acad. Titles |
| record_format | marc |
| spelling | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man ed. by Mike Clark Nottingham Acad. Titles 1993 XI, 182 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Antibodies, Monoclonal genetics Antibodies, Monoclonal therapeutic use Immunoglobulins Biotechnology Immunoglobulins Therapeutic use Protein Engineering Protein engineering Monoklonaler Antikörper (DE-588)4040094-3 gnd rswk-swf Rekombinante DNS (DE-588)4225578-8 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Antikörper (DE-588)4002290-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Antikörper (DE-588)4002290-0 s Therapie (DE-588)4059798-2 s DE-604 Monoklonaler Antikörper (DE-588)4040094-3 s Rekombinante DNS (DE-588)4225578-8 s DE-188 Clark, Mike Sonstige oth |
| spellingShingle | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man Antibodies, Monoclonal genetics Antibodies, Monoclonal therapeutic use Immunoglobulins Biotechnology Immunoglobulins Therapeutic use Protein Engineering Protein engineering Monoklonaler Antikörper (DE-588)4040094-3 gnd Rekombinante DNS (DE-588)4225578-8 gnd Therapie (DE-588)4059798-2 gnd Antikörper (DE-588)4002290-0 gnd |
| subject_GND | (DE-588)4040094-3 (DE-588)4225578-8 (DE-588)4059798-2 (DE-588)4002290-0 (DE-588)4143413-4 |
| title | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man |
| title_auth | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man |
| title_exact_search | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man |
| title_full | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man ed. by Mike Clark |
| title_fullStr | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man ed. by Mike Clark |
| title_full_unstemmed | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man ed. by Mike Clark |
| title_short | Protein engineering of antibody molecules for prophylactic and therapeutic applications in man |
| title_sort | protein engineering of antibody molecules for prophylactic and therapeutic applications in man |
| topic | Antibodies, Monoclonal genetics Antibodies, Monoclonal therapeutic use Immunoglobulins Biotechnology Immunoglobulins Therapeutic use Protein Engineering Protein engineering Monoklonaler Antikörper (DE-588)4040094-3 gnd Rekombinante DNS (DE-588)4225578-8 gnd Therapie (DE-588)4059798-2 gnd Antikörper (DE-588)4002290-0 gnd |
| topic_facet | Antibodies, Monoclonal genetics Antibodies, Monoclonal therapeutic use Immunoglobulins Biotechnology Immunoglobulins Therapeutic use Protein Engineering Protein engineering Monoklonaler Antikörper Rekombinante DNS Therapie Antikörper Aufsatzsammlung |
| work_keys_str_mv | AT clarkmike proteinengineeringofantibodymoleculesforprophylacticandtherapeuticapplicationsinman |